Email *

Message *

CANSWERIST® via @flipboard

Today's Tweets are Tomorrow's Posts
View my Flipboard Magazine.
View my Flipboard Magazine.
View my Flipboard Magazine.
View my Flipboard Magazine.

When you change the way you look at things, the things you look at change

Search This Blog

Monday, February 1, 2016

Flip②▶#SocialCurrentSee of a #CANSWERIST

Flip②▶CANswerWorth ARCHIVE |

Since our initial MCL diagnosis in April 2006, followed by an allogeneic stem cell transplant from an unrelated German donor, we have been following and blogging about cancer survival. Some ask what is a #CANSWERIST? That term has been coined to refer to any cancer survivor or anyone who cares for a cancer patient or survivor.  Our #SocialCurrentSee locations contain clips, links, stories, comments and assorted other content on these subjects.


VIDEO SOURCE : Ongoing clinical research at MD Anderson is finding promising new therapies for a rare and aggressive type of lymphoma that becomes resistant to treatment. Although mantle cell lymphoma (MCL) currently has no cure, combinations of new targeted therapy drugs are dramatically improving survival and treatment response rates for MCL patients. MD Anderson lymphoma specialists Jorge Romaguera, M.D. and Michael Wang, M.D., discuss these mantle cell lymphoma treatments and their search for new pathways that may lead to a cure.

SUBSCRIBE to This Blog

Enter your email address:

Delivered by FeedBurner

Today ▶ Canswerist®

▶ SLIDESHOW   ▶ NUZZEL “NEXT” story archive for 15Feb18 ▶ Alzheimer’s Cure in sight?   ▶ Health concerns for the 5...

Privacy Notice

Privacy Notice: The sites and blogs of ALTACITIES conform to these PRIVACY PRACTICES.